Trevena
1 known investors
Find your way into Trevena
Sign up to see every warm intro you have to Trevena
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Trevena team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Trevena develops and commercializes innovative pharmaceutical therapies for central nervous system disorders. The company has an FDA-approved drug (OLINVYK) and multiple investigational candidates targeting migraine, opioid use disorder, and neuropathic pain.
Investors · 1
Frequently asked questions
- What does Trevena do?
- Trevena develops and commercializes innovative pharmaceutical therapies for central nervous system disorders. The company has an FDA-approved drug (OLINVYK) and multiple investigational candidates targeting migraine, opioid use disorder, and neuropathic pain.
- Who are Trevena's investors?
- Trevena's investors include New Enterprise Associates (NEA).